Is Ascendis Pharma A/S halal to invest in?

According to Musaffa's Shariah screening methodology, Ascendis Pharma A/S (ASND) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Ascendis Pharma A/S a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ascendis Pharma A/S using these criteria to determine its compliance status.

Can Muslims buy shares of Ascendis Pharma A/S?

Muslim investors may consider investing in Ascendis Pharma A/S if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Ascendis Pharma A/S classified as HALAL?

Musaffa determines the Shariah status of Ascendis Pharma A/S by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Ascendis Pharma A/S updated?

The Shariah compliance status of Ascendis Pharma A/S may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Ascendis Pharma A/S become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Ascendis Pharma A/S?

You can check the latest Shariah compliance status of Ascendis Pharma A/S on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ASND Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 05, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Ascendis Pharma A/S (ASND)

Based on 24 analysts giving stock ratings to Ascendis Pharma A/S in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Ascendis Pharma A/S. Stock Analysis ASND

United States Health Care Large Cap Report: 2025 Annual

Ascendis Pharma A/S is a DK-based company operating in Biotechnology industry. Ascendis Pharma A/S is a Denmark‑based biopharmaceutical company operating within the life sciences and biotechnology sector. The firm scope of activity includes discovery, development, and commercialization of innovative therapies for rare diseases and serious chronic conditions with significant unmet medical needs where a clinically validated parent drug or pathway is suitable to company technologies. Ascendis Pharma A/S focuses on the endocrinology area and has a pipeline of three independent rare disease product candidates, such as Growth Hormone Deficiency (GHD), Hypoparathyroidism and Achondroplasia. The second therapeutic area is oncology, where the company focuses immunotherapy to targeted therapies.

Key Statistics of Ascendis Pharma A/S (ASND)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$239.47$243.59

Today's Open

$243.59

Volume

471.35K

P/E Ratio (TTM)

52 Week Range

$150.89$250.74

Market Cap

14.05B

Avg. Volume

778.99K

Dividend Yield

Financial Metrics & Statements of Ascendis Pharma A/S (ASND)

FAQ's for Ascendis Pharma A/S (ASND)

According to Musaffa’s Shariah screening methodology, Ascendis Pharma A/S (ASND) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.